N Brereton Medical Technologies LLC

N Brereton Medical Technologies LLC is a medical technology company focused on addressing opioid dependency, specifically through the development of FenBlock™. FenBlock is a patented medical device designed to serve as a barrier for fentanyl patches, facilitating a controlled and graduated titration process. The device utilizes the Brereton Barrier™, which is constructed from 3M-patented, FDA-certified, non-transdermal materials, allowing patients to safely manage their medication tapering under the guidance of healthcare providers. The company’s mission centers on providing innovative, patient-centered solutions for individuals struggling with dependency, with an emphasis on regulatory compliance and scientific rigor as they pursue FDA approval. By offering a structured, measurable approach to reducing medication intake, the company aims to help patients successfully navigate their recovery journey while maintaining effective pain management standards. The company works closely with health science experts to ensure their technology aligns with established clinical and regulatory benchmarks for opioid treatment devices. Their work is motivated by a commitment to improving patient outcomes and quality of life for those impacted by fentanyl dependency. Partners and stakeholders are kept informed throughout the development process, with the company actively engaging with medical industry associations and government representatives to advance their solutions in the field of addiction recovery and pain management.